These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9151217)

  • 1. Gene therapy for glioblastoma [correction of gliobestome] multiform: in vivo tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir.
    Stockhammer G; Brotchi J; Leblanc R; Bernstein M; Schackert G; Weber F; Ostertag C; Mulder NH; Mellstedt H; Seiler R; Yonekawa Y; Twerdy K; Kostron H; De Witte O; Lambermont M; Velu T; Laneuville P; Villemure JG; Rutka JT; Warnke P; Laseur M; Mooij JJ; Boëthius J; Mariani L; Gianella-Borradori A
    J Mol Med (Berl); 1997 Apr; 75(4):300-4. PubMed ID: 9151217
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical protocol. Liposomal gene therapy with the herpes simplex thymidine kinase gene/ganciclovir system for the treatment of glioblastoma multiforme.
    Voges J; Weber F; Reszka R; Sturm V; Jacobs A; Heiss WD; Wiestler O; Kapp JF
    Hum Gene Ther; 2002 Mar; 13(5):675-85. PubMed ID: 11916490
    [No Abstract]   [Full Text] [Related]  

  • 3. A phase I study of recombinant adenovirus vector-mediated intraperitoneal delivery of herpes simplex virus thymidine kinase (HSV-TK) gene and intravenous ganciclovir for previously treated ovarian and extraovarian cancer patients.
    Alvarez RD; Curiel DT
    Hum Gene Ther; 1997 Mar; 8(5):597-613. PubMed ID: 9095411
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene therapy for the treatment of recurrent pediatric malignant astrocytomas with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system.
    Raffel C; Culver K; Kohn D; Nelson M; Siegel S; Gillis F; Link CJ; Villablanca JG; Anderson WF
    Hum Gene Ther; 1994 Jul; 5(7):863-90. PubMed ID: 7981311
    [No Abstract]   [Full Text] [Related]  

  • 5. Side populations of glioblastoma cells are less sensitive to HSV-TK/GCV suicide gene therapy system than the non-side population.
    Hu W; Liu W
    In Vitro Cell Dev Biol Anim; 2010 Jun; 46(6):497-501. PubMed ID: 20135358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells.
    Berenstein M; Adris S; Ledda F; Wolfmann C; Medina J; Bravo A; Mordoh J; Chernajovsky Y; Podhajcer OL
    Cancer Gene Ther; 1999; 6(4):358-66. PubMed ID: 10419054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group.
    Shand N; Weber F; Mariani L; Bernstein M; Gianella-Borradori A; Long Z; Sorensen AG; Barbier N
    Hum Gene Ther; 1999 Sep; 10(14):2325-35. PubMed ID: 10515452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors.
    Kun LE; Gajjar A; Muhlbauer M; Heideman RL; Sanford R; Brenner M; Walter A; Langston J; Jenkins J; Facchini S
    Hum Gene Ther; 1995 Sep; 6(9):1231-55. PubMed ID: 8527482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer.
    Hall SJ; Mutchnik SE; Chen SH; Woo SL; Thompson TC
    Int J Cancer; 1997 Jan; 70(2):183-7. PubMed ID: 9009158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suicide genes against brain tumors.
    Paillard F
    Hum Gene Ther; 1998 Jan; 9(1):3-4. PubMed ID: 9458236
    [No Abstract]   [Full Text] [Related]  

  • 11. HSV-TK/IL-2 gene therapy for glioblastoma multiforme.
    Barzon L; Pacenti M; Franchin E; Colombo F; Palù G
    Methods Mol Biol; 2009; 542():529-49. PubMed ID: 19565921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.
    Eck SL; Alavi JB; Alavi A; Davis A; Hackney D; Judy K; Mollman J; Phillips PC; Wheeldon EB; Wilson JM
    Hum Gene Ther; 1996 Aug; 7(12):1465-82. PubMed ID: 8844206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.
    Rainov NG
    Hum Gene Ther; 2000 Nov; 11(17):2389-401. PubMed ID: 11096443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity and immunologic effects of in vivo retrovirus-mediated gene transfer of the herpes simplex-thymidine kinase gene into solid tumors.
    Culver KW; Moorman DW; Muldoon RR; Paulsen RM; Lamsam JL; Walling HW; Link CJ
    Cold Spring Harb Symp Quant Biol; 1994; 59():685-90. PubMed ID: 7587131
    [No Abstract]   [Full Text] [Related]  

  • 15. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration.
    Niranjan A; Moriuchi S; Lunsford LD; Kondziolka D; Flickinger JC; Fellows W; Rajendiran S; Tamura M; Cohen JB; Glorioso JC
    Mol Ther; 2000 Aug; 2(2):114-20. PubMed ID: 10947938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted gene therapy for cancer: herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumour immunity that can be augmented by co-expression of cytokines in the tumour cells.
    Vile RG; Diaz RM; Castleden S; Chong H
    Biochem Soc Trans; 1997 May; 25(2):717-22. PubMed ID: 9191190
    [No Abstract]   [Full Text] [Related]  

  • 17. Adeno-associated virus vector containing the herpes simplex virus thymidine kinase gene causes complete regression of intracerebrally implanted human gliomas in mice, in conjunction with ganciclovir administration.
    Mizuno M; Yoshida J; Colosi P; Kurtzman G
    Jpn J Cancer Res; 1998 Jan; 89(1):76-80. PubMed ID: 9510479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial.
    Prados MD; McDermott M; Chang SM; Wilson CB; Fick J; Culver KW; Van Gilder J; Keles GE; Spence A; Berger M
    J Neurooncol; 2003 Dec; 65(3):269-78. PubMed ID: 14682377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for metastatic malignant melanoma: evaluation of tolerance to intratumoral injection of cells producing recombinant retroviruses carrying the herpes simplex virus type 1 thymidine kinase gene, to be followed by ganciclovir administration.
    Klatzmann D
    Hum Gene Ther; 1996 Jan; 7(2):255-67. PubMed ID: 8788175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsulation of packaging cell line results in successful retroviral-mediated transfer of a suicide gene in vivo in an experimental model of glioblastoma.
    Martinet O; Schreyer N; Reis ED; Joseph JM
    Eur J Surg Oncol; 2003 May; 29(4):351-7. PubMed ID: 12711288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.